Characteristics and Outcomes of Endometriosis at Dr. M. Djamil Padang General Hospital in 2023

Characteristics and Outcomes of Endometriosis at Dr. M. Djamil Padang General Hospital in 2023 DOI: https://doi.org/10.25077/aoj.9.2.205-212.2025Keywords: Characteristics, Outcomes, EndometriosisAbstract Background. Endometriosis stands as a prevalent benign gynecological condition. It involves the growth of tissue resembling the endometrium outside the uterus, typically impacting the ovaries and peritoneum. Symptoms commonly include premenstrual discomfort and dysmenorrhea. Objective. Knowing the characteristics and outcomes of endometriosis at Dr. M. Djamil Padang General Hospital for the 2023 period. Method. This study is descriptive research aimed at identifying the characteristics of endometriosis among patients at Dr. M. Djamil Padang General Hospital. Conducted in 2023, the study population initially consisted of 129 endometriosis patients. One year later, follow-up was conducted with 73 patients to assess recurrence. Result. There were more patients of reproductive age (97.7%, totaling 126 individuals) than perimenopausal age. The most common complaints reported by patients seeking treatment were dysmenorrhea (81.4%) and non-menstrual abdominal pain (7.8%). The majority of patients were nulliparous (87.6%), followed by multiparous (7%). In terms of BMI categories, most subjects were classified as normal weight (38%) or obese class I (19.4%). Endometriosis lesions were predominantly located in the internal pelvis, particularly in the ovaries (58.1%). Among patients experiencing infertility, the duration was often ≥5 years (31.8%). Nearly all patients received a three-month course of leuprolide acetate injections (97.3%), with additional therapy involving dienogest tablets for three months in 38.4% of cases. Recurrence of symptoms occurred in only 6.8% of patients, while 6.8% of patients became pregnant following treatment. Conclusion. This study concludes that the incidence of endometriosis is high in women of reproductive age. Providing good education about endometriosis is important in order to reduce the delay in diagnosis of this disease so that it can be treated when the stadium was still mild. References 1. Allaire C, Bedaiwy MA, Yong PJ. Diagnosis and management of endometriosis. CMAJ. 2023 Mar 14;195(10):E363-E371. DOI:10.1503/cmaj.220637 2. Anastasilakis AD, Polyzos SA, Vorkas PA, Gkiomisi A, Yavropoulou MP, et.al. Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study. J Clin Med. 2023 Aug 21;12(16):5430. DOI:10.3390/jcm12165430 3. Diagnosis of endometriosis in the 21st century. Kiesel L, Sourouni M. Climacteric. 2019;22:296–302. DOI:10.1080/13697137.2019.1578743 4. Hoffman. Endometriosis. In: Williams Gynecology. 3rd ed. New York: Mc Graw Hill Education; 2016. p.230-48 5. Hidayat A, Hendry D. Karakteristik penderita endometriosis dan adenomiosis di RSUP Dr. M. Djamil padang periode januari 2017-oktober 2018. Andalas Obstetrics and Gynecology Journal. 2019; 3: 28-41.45. 6. Marhenriyanto W, Hendry D. Comparison of pain scale in patients with endometriosis cysts and adenomyosis before surgery, after surgery and after giving analog GnRH. Andalas Obstetrics and Gynecology Journal. 2020; 4.1:35-47. 7. Origins and progression of adolescent endometriosis. Brosens I, Gargett CE, Guo SW, Puttemans P, Gordts S, Brosens JJ, Benagiano G. Reprod Sci. 2016;23:1282–1288. DOI:10.1177/1933719116637919 8. Callahan. Endometriosis and adenomyosis. In: Blueprints Obstetrics and Gynecology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2013. p.204-14 9. Endometriosis and infertility: epidemiology and evidence-based treatments. Ozkan S, Murk W, Arici A. Ann N Y Acad Sci. 2008;1127:92–100. DOI:10.1196/annals.1434.007 10. Fritz M, Speroff L. Endometriosis. In: Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Lippincott William & Wilkin; 2011. p.1221-48 11. Oocyte quality is decreased in women with minimal or mild endometriosis. Xu B, Guo N, Zhang XM, Shi W, Tong XH, Iqbal F, Liu YS. Sci Rep. 2015;5:10779. DOI:10.1038/srep10779 12. Lindsay SF, Luciano DE, Luciano AA. Emerging therapy for endometriosis. Expert opinion on emerging drugs. 2015;20(3):449-61. 13. Parazzini F, Esposito G, Tozzi L, Noli S, Bianchi S. Epidemiology of endometriosis and its comorbidities. European Journal Obstetrics & Gynecology Reproductive Biology. 2016; 209: 3-7. 14. Advincula A, Truong M, Lobo RA. Endometriosis: etiology, pathology, diagnosis, management. . Coprehensive Gynecology. 7th ed. Philadelphia: Mosby Elsevier; 2017. p. 423-42 15. Lee HJ, Park YM, Jee BC, Kim YB, Suh CS. Various anatomic locations of surgically proven endometriosis : A single-center experience. Obstetrics & Gynecology Science. 2015; 58: 53-8. DOI:10.5468/ogs.2015.58.1.53 16. Tissot M, Lecointre L, Faller E, Afors K, Akladios C, Audebert A. Clinical presentation of endometriosis identified at interval laparoscopic tubal sterilization: Prospective series of 465 cases. J Gynecol Obstet Hum Reprod. 2017;1-4 17. Anastasilakis AD, Polyzos SA, Vorkas PA, Gkiomisi A, Yavropoulou MP, et.al. Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study. J Clin Med. 2023 Aug 21;12(16):5430. 18. Kelley A, Moravek M. Diagnosis and management of endometriosis. In: Handbook of Gynecology. Los Angeles: Springer; 2017. p.281-90 Downloads Published How to Cite Issue Section License Copyright (c) 2025 Fahrur Rozi Illahi, Mondale Saputra, Haviz Yuad This work is licensed under a Creative Commons Attribution 4.0 International License.